FIFTH THIRD BANCORP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$82,000
-56.4%
378
-76.9%
0.00%
-100.0%
Q4 2020$188,000
+88.0%
1,633
+59.0%
0.00%0.0%
Q3 2020$100,000
-5.7%
1,027
+18.9%
0.00%0.0%
Q2 2020$106,000
+58.2%
864
+13.5%
0.00%
Q1 2020$67,000
+179.2%
761
+238.2%
0.00%
Q4 2019$24,000
-22.6%
225
-15.4%
0.00%
Q3 2019$31,000
-34.0%
266
-3.3%
0.00%
Q2 2019$47,000
+2.2%
2750.0%0.00%
Q1 2019$46,000
+70.4%
2750.0%0.00%
Q4 2018$27,000
-43.8%
2750.0%0.00%
Q3 2018$48,000
+54.8%
275
+22.2%
0.00%
Q2 2018$31,000
+933.3%
225
+800.0%
0.00%
Q1 2018$3,0000.0%250.0%0.00%
Q4 2017$3,0000.0%250.0%0.00%
Q3 2017$3,0000.0%250.0%0.00%
Q2 2017$3,0000.0%250.0%0.00%
Q1 2017$3,000
-92.5%
25
-91.6%
0.00%
Q3 2016$40,000
-58.3%
299
-71.5%
0.00%
-100.0%
Q2 2016$96,000
+65.5%
1,049
+31.3%
0.00%0.0%
Q1 2016$58,000
-3.3%
799
-7.4%
0.00%0.0%
Q4 2015$60,000
-24.1%
8630.0%0.00%0.0%
Q3 2015$79,000
-14.1%
863
+15.1%
0.00%0.0%
Q2 2015$92,000
+12.2%
750
-16.7%
0.00%0.0%
Q1 2015$82,000
+34.4%
9000.0%0.00%0.0%
Q4 2014$61,000
+52.5%
900
+80.0%
0.00%
Q3 2014$40,0005000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders